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The Radiotherapy of Malignant Disease. Eds. E.C.
Easson and R.C.S. Pointon. Springer - 1984,
£54.00, xii+474 pages, ISBN 3 540 13104 3.
The final arrival of the new Manchester book is of
great interest to all of us in clinical oncology. It is
very well produced and printed by Springer, and
the price is standard for a book of this size in 1985.
It shows all the virtues of Ralston Paterson's 1947
and 1963 books and the spirit of "R.P.", the father
figure, can be glimpsed through most of the book,
with further influence, but no radical changes, from
Eric Easson, Robert Gibb and Bob Pointon. The
Manchester philosophy of standard treatment
policies, clearly prescribed initially, continued and
completed whenever possible, without modification,
with vigorous dosage over 1, 8, 15 or 20 daily
fractions, is very much alive. Radium has been
replaced by caesium, but needles rather than
iridium wire are used, and the old insistence on
good planning, done by the doctors themselves, is
unaltered.
The chapters on philosophy and principles by
Eric Easson himself, and on radiobiology by
Malcolm Sutton and Jolyon Hendry give one a
good idea of the background. The "mould room
practice" chapter by Pointon and Dianne Studd is
first class and this and the physics chapter by
Greene and Stephenson alone make the book well
worth buying, though there is much more. There is
a good chapter on chemotherapy by Wilkinson and
Fox which is restrained and sensible, including
sections on etoposide and cis-platinum for example,
but not mentioning the newer analogues or possible
substitutes to cis-platinum and doxorubicin. There
is a chapter and appendices on clinical trials and on
Paterson-Parker mould and implant calculations
and on clinical staging.
The clinical chapters describe exactly what is
done at the Christie. If one follows the treatment
given, one can rely on achieving as good results as
are obtained almost anywhere by radiotherapy,
though sometimes probably with slightly more
severe acute and long-term normal tissue effects.
Derek Crowther comes in to collaborate with Ian
Todd and Peter Wilkinson on lymphoma, a very
good chapter with treatment results and
recommendations for further reading. Gynaeco-
logical cancer - Moya Cole and Robin Hunter - is
well done, with full description of the classical
Manchester technique with insertions in the knee-
chest position, followed by a description of caesium
after loading using the Selectron system. Only
interim recommendations are given for correction
factors to dosage from higher dose-rates. The
breast chapter by Ribeiro is interesting, kilovoltage
therapy is still given for chest wall treatments
though electron treatment is also described.
Hormone treatment with receptor assays is outlined
but chemotherapy is dealt with in the chemo-
therapy chapter. "Adjuvant" chemotherapy is not
advocated and is barely mentioned. The "head and
neck" - Duthie, Gupta and Pointon - now includes
mouth, lip and cervical nodes and is good. Space
does not allow mention of the other tumour sites -
all are well done.
This is essentially, as described, a Manchester
handbook of radiotherapy. Anybody who takes
radiotherapy seriously (and of course this means
everybody!) should read it, there is much to be
gained by Londoners as well as by Americans and
indeed all clinical oncologists. There ought,
however, in the next edition - much sooner please
than twenty years ahead I to be a mention of
results, more references and "further reading",
more discussion of radiotherapy combination with
chemotherapy, and some background comparison
at least with what is done outside Manchester.
Keith E. Halnan
Advances in Cancer Research. Vol. 41. Eds. G.
Klein and S. Weinhouse. Academic - 1984, £38.50,
ix+383 pages, ISBN 0 12 006641 6.
The volumes in this series are usually first class and
this is no exception - its seven articles provide a
veritable goldmine of information and cover a very
wide area.
The first chapter by Byers and Graham reviews
the epidemiology of diet and cancer and
summarises a fascinating spectrum of dietary
factors and their association with different forms of
human cancer. The problems of measuring "diet",
of changes in diet with time and of relating dietary
causal factors to cancers which appear some six to
20 years later are lucidly discussed, as are recent
intervention studies involving changes in diet.
Gordon writes on the molecular aspects of
immunoglobulin expression by human B cell
leukaemias and lymphomas and this is an excellent
far-ranging discussion on B cell malignancies. Our
understanding of B cell systems has undergone a
revolution over recent years due to the development
and use of monoclonal antibodies and recombinant138 BOOK REVIEWS
DNA probes. There is a very good summary of the
progress made in unravelling the events occurring
in Burkitt's lymphoma and the author discusses the
probable involvement of recombinational error that
occurs in allelic exclusion - particularly for heavy
chain genes - in the production of inter-
chromosomal non-homologous translocations that
are found in these lymphomas. There is, however,
no mention of the few Burkitt lymphoma cases that
have recently been reported which apparently do
not appear to involve the Ig locus on chromosome
14 or the light chain loci on chromosomes 2 and
20.
Hynes, Groner and Michalides provide an
illuminating chapter on the mouse mammary
tumour virus, one of the slowly transforming retro-
viruses that do not carry an oncogene and which
transform host cells by the process of insertional
mutagenesis. This is a very comprehensive,
informative and stimulating review on the
molecular aspects of MMV in relation to mammary
tumours and includes an intriguing account of the
involvement of MMV in the T cell leukaemias in
GR strain mice.
The chapter by Harnden, Morton and
Featherstone deals with dominant susceptibility to
cancer in man. This is again a very comprehensive
and informative review and is a must for all those
interested in inherited predispositions to cancer.
Such familial predispositions provide us with clues
in unravelling the events that occur in similar, but
sporadic, cancers and the discussions on retino-
blastoma in this chapter are particularly rewarding.
It is just unfortunate that this paper went to press
before the publication by Cavenee et al. (Nature,
1983, 305, 779) demonstrating, through the use of
DNA polymorphisms, the development of somatic
homozygosity at the Rb-i locus on chromosome 13
in Rb tumour cells, in individuals who were con-
stitutional heterozygotes. Since then a number of
groups have also used cloned probes to
demonstrate the somatic development of hemi-
zygosity, or homozygosity, in chromosome llp in
Wilm's tumour (Nature, 1984, 309, 170-178),
underlining the importance of these studies on
inherited cancer predispositions in contributing to
our understanding of the processes involved in
neoplastic transformations.
B cell malignancies also provide the topic covered
by Mellstedt, Holm and Bjorkholm who review the
immunology of the B cell clones and immuno-
regulating T cell sub-sets in multiple myeloma,
Waldenstrom's macroglobulinemia and their benign
counterparts. The immunological theme is
continued in the article by Schreiber on the inter-
actions between lymphocyte clones in the immune
response to tumour-specific antigens and the
influence of such idiotype network interactions in
the regulation of tumour immunity, and by
Madrano and Dutrillaux's rather descriptive and
comparative account of the chromosomal locations
of the Ig gene complexes in man, mouse and rabbit.
I don't believe that many people buy books in
this Annual Review Series for their personal use,
for volumes in this series are usually to be chased
up in good libraries. This book, however, aside
from being an obligatory requirement for any
library, is of very high quality and of sufficient
interest to most scientists involved in the
fundamentals of cancer research for them to dip
into their own pockets. I strongly recommend it.
H.J. Evans
Human Trophoblast Neoplasms: Proceedings of the
World Congress on Trophoblast Neoplasms, Nairobi,
1982. Advances in Experimental Medicine and
Biology. Vol. 176. Eds. R.A. Patillo and R.O.
Hussa. Plenum - 1984, £72.50, x+505 pages, ISBN
0 306 41735 9.
This book derives from the First World Congress
on Trophoblast Neoplasms held in Nairobi, Kenya,
in October 1982. Because of the time-lapse before
publication, I approached its contents with a
slightly jaundiced view. However, as I read it, I
discovered how mistaken I had been. It provides a
truly world view with eminent contributors from
Africa, Europe, the Far East, India, the Middle
East and North America, thus fulfilling one of its
aims - namely "to combine Western technology
with the clinical experience in the developing world
in a common pursuit of the study and eradication
of trophoblast neoplasm". The chapters are
referenced up to 1984 and the issues tackled are
highly relevant. They are gathered together within
sections on pregnancy and neoplasia; immunology,
gestation and neoplasia; genetic origins;
epidemiology; HCG; clinical staging and chemo-
therapy and clinical management. Each section is
preceded by a useful brief overview encapsulating
its salient features and highlighting growth areas.
I remain to be convinced by Takeuchi's hypo-
thesis regarding the immune selection of
conceptuses into either spontaneous abortion or
hydatidiform mole after early embryonic death. The
work by Szulman and Surti on cytogenetic and
morphological aspects of complete and partial
moles is already standard reference: the genetic
studies of Lawler continue to be fascinating. All
chapters are well written (and edited) and the whole
amply fulfils its major objective "to provide a
broad perspective to (sic) neoplasms of the human
trophoblast". This is a book which all thos
involved in the study and/or treatment of